The Journal of Practical Medicine ›› 2024, Vol. 40 ›› Issue (12): 1755-1761.doi: 10.3969/j.issn.1006-5725.2024.12.024

• Reviews • Previous Articles     Next Articles

Research progress of circrna and atherosclerotic ischemic stroke

Chunling PAN1,Xueli YI2,3,4,Li SU5,Shengshan YUAN5,Guijiang WEI2,3,4()   

  1. Youjiang Medical College for Nationalities,Baise 533000,China
  • Received:2023-10-08 Online:2024-06-25 Published:2024-06-14
  • Contact: Guijiang WEI E-mail:252787634@qq.com

Abstract:

Stroke is one of the main diseases endangering the health and life of the middle-aged and elderly, and in recent years it shows a younger trend.It has the characteristics of high incidence, mortality and disability rate. Atherosclerosis is the main intervention target for stroke prevention and treatment.CircRNA is highly expressed in the cerebrovascular system and plays an important regulatory role in the pathogenesis of ischemia-reperfusion and ischemic stroke.This paper reviews the mechanism of circRNA and miRNA molecular network in the pathophysiological process of atherosclerosis, ischemic stroke and ischemia-reperfusion injury, so as to provide theoretical support for the application of circRNA in gene diagnosis and drug treatment of atherosclerotic ischemic stroke.

Key words: circRNA, ischemic stroke, atherosclerotic, pathophysiological process, prognosis, biomarkers

CLC Number: